Last night, family planning experts said a reversible male contraceptive could benefit millions of couples where the woman cannot take the Pill for medical reasons.
And it would save men from being trapped into having children they did not want, they added. With global sales of contraceptives topping £13 billion a year, the market for a reversible male contraceptive could be huge, but some cast doubt on the idea of a male pill, doubting women will trust men to take it.
Lead researcher Professor John Howl, of Wolverhampton University, last night described how effective their sperm-stopping agent had been in lab tests.
He said: "The results are startling - and almost instant. When you take healthy sperm and add our compound, within a few minutes the sperm basically cannot move."
Male infertility is often the result of poorly moving sperm, called "low motility". Using this, the Wolverhampton team, together with Portuguese researchers, made a compound called a cell-penetrating peptide, which gets inside sperm and brings them to a standstill. Prof Howl said: "This is a totally unique approach - nobody else has ever done this before."
Peptides are short chains of amino acids that can influence how human cells work. They occur naturally but biochemists can make synthetic versions. Prof Howl and colleague Dr Sarah Jones first demonstrated that certain "cell-penetrating peptides" could smuggle themselves inside sperm cells, like a Trojan horse.
Then they joined forces with IVF experts at Aveiro University in Portugal, who had identified the crucial protein responsible for putting the wiggle into sperm tails.
The two universities created a bespoke peptide which turns that protein off. They tested the approach in the petri dish on bovine and human sperm, with similarly impressive results, and will soon publish their results.
Prof Howl said they hoped to start live animal tests in two to three years, thanks in part to a £175,000 Portuguese grant. It typically takes three to five years to bring a new drug to market after animal trials, so the final product could be available as early as 2021.
Prof Howl said it was "too early to say" if the end result would be a pill, a nasal spray or a sub-skin implant, but they were all possibilities.
John Guillebaud, emeritus professor of family planning and reproductive health at University College, London, said a reversible male contraceptive would be "of enormous benefit to many couples, such as those where the woman cannot take the Pill for medical reasons - for instance due to migraine with aura or an increased risk of blood clots".
He added: "It would also help men who want to have control over their own fertility - for example, to ensure they do not get trapped into having a child by a woman who says she is on the Pill, but isn't."
An Anglia Ruskin University study found half of 134 women questioned were concerned their partner would forget to take a contraceptive, but Prof Guillebaud, who is behind another male pill venture, said this was a "widely held myth". He cited a bigger survey of 1,894 women, conducted in Scotland, China and South Africa, which found only 2 per cent would not trust their partner.
Professor Geeta Nargund, medical director of CREATE fertility clinics, said: "If this proves safe and effective, I'm sure women would welcome it. It's about time men took responsibility for contraception."
